<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: skin irritation</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Pediatricians endorse new acne treatment guidelines</title>
   	 <description>(HealthDay)—Pimples have long been the bane of teenage existence, but pediatricians say there is now enough evidence on effective treatments to put out the first guidelines on battling acne in children.</description>
     <link>http://medicalxpress.com/news/2013-05-pediatricians-endorse-acne-treatment-guidelines.html</link>
	 <category>Pediatrics</category>
	 <pubDate>Mon, 06 May 2013 09:50:01 EST</pubDate>
	 <guid isPermaLink="false">news287050651</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/2-1-pediatrician.jpg" width="90" height="90" />
</item>
<item>
     <title>First OTC drug approved for women with overactive bladder</title>
   	 <description>(HealthDay)—The drug Oxytrol has been approved by the U.S. Food and Drug Administration as the first over-the-counter treatment for women 18 and older with overactive bladder.</description>
     <link>http://medicalxpress.com/news/2013-01-otc-drug-women-overactive-bladder.html</link>
	 <category>Medications</category>
	 <pubDate>Fri, 25 Jan 2013 13:11:25 EST</pubDate>
	 <guid isPermaLink="false">news278341876</guid>
	 
</item>
<item>
     <title>Researcher develops non-toxic dandruff shampoo</title>
   	 <description>Dandruff sufferers now have a non-toxic product to treat the condition, says a researcher at Georgia Health Sciences University.</description>
     <link>http://medicalxpress.com/news/2012-04-non-toxic-dandruff-shampoo.html</link>
	 <category>Other</category>
	 <pubDate>Mon, 30 Apr 2012 14:26:35 EST</pubDate>
	 <guid isPermaLink="false">news255014657</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/ghsuresearch.jpg" width="90" height="84" />
</item>
<item>
     <title>New drug now available for actinic keratosis</title>
   	 <description>A new topical gel now available by prescription significantly decreases the amount of time needed to treat actinic keratosis, a skin condition that is a common precursor to skin cancer, according to a multi-center trial led by researchers at Mount Sinai School of Medicine. The gel, called ingenol mebutate, is applied to the skin for just a few days, making it quicker and even more effective as current therapies require weeks to months to apply. The Phase III study results of the trial are published in the March 15, 2012 issue of the The New England Journal of Medicine.</description>
     <link>http://medicalxpress.com/news/2012-03-drug-actinic-keratosis.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Wed, 14 Mar 2012 18:19:47 EST</pubDate>
	 <guid isPermaLink="false">news250967973</guid>
	 
</item>


</channel>
</rss>
